http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 07 May 2024 14:44:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html <div class="xn-content"> <p><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO, Calif.</location></span>, <span class="legendSpanClass"><chron>May 7, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>May 9, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Present+at+the+Emerging+Growth+Conference+on+May+9%2C+2024/23185702.html Tue, 07 May 2024 14:44:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBP RGBPD RGBPP RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/Press+Releases/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html <div class="xn-content"> <p class="prntac"><i><span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the <span>Emerging Growth Conference</span>.</i></p> <p><span class="legendSpanClass"><location value="LU/us.ca.sandgo" idsrc="xmltag.org" >SAN DIEGO</location></span>, <span class="legendSpanClass"><chron>April 2, 2024</chron></span> /PRNewswire/ -- <span value="OTC-PINK:RGBP" idsrc="xmltag.org" >Regen BioPharma, Inc.</span> (OTC PINK: RGBP) (OTC PINK: RGBPP), a biotechnology company advancing a diverse pre-clinical pipeline spanning cell therapies, RNA vaccines, RNA and DNA therapeutics and small molecule drugs will be presenting at the <span>Emerging Growth Conference</span> on <chron>April 4, 2024</chron> (<a target="_blank" href="https://emerginggrowth.com/conference/" target="_blank" rel="nofollow">https://emerginggrowth.com/conference/</a>).</p> <p>This live, interactive online event will give existing shareholders and http://www.streetinsider.com/PRNewswire/Regen+BioPharma%2C+Inc.+to+Discuss+Plans+to+Move+Forward+with+HemaXellerate+into+Clinical+Phase+1+at+the+Emerging+Growth+Conference+on+April+4%2C+2024/23013195.html Tue, 02 Apr 2024 09:30:00 -0400 A.42938529 O.20639606 O.22480982 RGBP RGBPD RGBPP